Table 3.
Summary of Mutations Reported by the Abbott RT MTBRIF/INH Assay
Drug | Mutation Information | n | % | |
---|---|---|---|---|
Rif | Total | 51 | 100% | |
PB4- | 18 | 35.3% | ||
PB2- | 11 | 21.6% | ||
PB5- | 11 | 21.6% | ||
PB7- | 6 | 11.8% | ||
PB2-, PB5- | 3 | 5.9% | ||
PB6- | 1 | 1.9% | ||
Mutation not listed | 1 | 1.9% | ||
INH | Total | 43 | 100% | |
katG | inhA | |||
315T1 | 33 | 76.7% | ||
−15T | 7 | 16.3% | ||
315T1 | −15T | 1 | 2.3% | |
MUT | 1 | 2.3% | ||
MUT | 1 | 2.3% |